FDA Panel Narrowly Supports BioMimetic's Augment Synthetic Bone Graft
FDA's Orthopedic and Rehabilitation Devices advisory panel narrowly supported approval of BioMimetic Therapeutics’ Augment synthetic bone graft May 12.
FDA's Orthopedic and Rehabilitation Devices advisory panel narrowly supported approval of BioMimetic Therapeutics’ Augment synthetic bone graft May 12.